Activest Wealth Management’s TherapeuticsMD TXMD Stock Holding History

Activest Wealth Management’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$81	Hold	40	–	–	﹤0.01%	1016
2026 Q2	$88	Hold	40	–	–	﹤0.01%	1254
2026 Q1	$81	Hold	40	–	–	﹤0.01%	1165
2025 Q4	$65	Hold	40	–	–	﹤0.01%	1075
2025 Q3	$43	Hold	40	–	–	﹤0.01%	1092
2025 Q2	$46	Hold	40	–	–	﹤0.01%	998
2025 Q1	$37	Hold	40	–	–	﹤0.01%	1000
2024 Q4	$34	Hold	40	–	–	﹤0.01%	800
2024 Q3	$66	Hold	40	–	–	﹤0.01%	532
2024 Q2	$64	Buy	+40	New	+$81	﹤0.01%	501

Other funds holding TXMD

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Ashton Thomas Private Wealth Scottsdale, Arizona $4.98B AUM 21.09% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $92B AUM 22.91% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Provenance Wealth Advisors Fort Lauderdale, Florida $1.69B AUM 11.53% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Activest Wealth Management's TXMD Position: Q3 2026 in Review

Activest Wealth Management held its TherapeuticsMD (TXMD) position steady in Q3 2026 at 40 shares worth $81. The position accounts for ﹤0.01% of the portfolio, ranked #1016.

Activest Wealth Management first reported a position in TXMD in Q2 2024 and has held it in 10 quarters since. The position peaked at $88 in Q2 2026. 13 funds tracked by Wall St. Rank hold TXMD as of Q3 2026.

Activest Wealth Management held 40 shares of TherapeuticsMD worth $81 as of Q3 2026.
Activest Wealth Management left its TherapeuticsMD share count unchanged in Q3 2026.
TherapeuticsMD made up ﹤0.01% of Activest Wealth Management's portfolio in Q3 2026, its #1016 holding.
Activest Wealth Management first reported a position in TherapeuticsMD in Q2 2024 and has held it in 10 quarters since.
Activest Wealth Management's TherapeuticsMD position peaked at $88 in Q2 2026.
13 funds tracked by Wall St. Rank held TherapeuticsMD as of Q3 2026.

Based on Activest Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.